Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer.  
The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, “Erleada!”

It’s a pill that you take – I believe – four times a day (check with your doctor).  Many of the articles about Erleada will tell you how FDA approval came from the SPARTAN clinical trial and how that trial was conducted.  Don’t get lost in the woods on that one.  

The take home is this.  Erleada helped delay metastasis by a couple of years, which is a good thing.  But we don’t know yet how much longer those men in the trial lived with Erleada versus those taking a placebo.   And we don’t know how those on Erleada felt, day to day.  How was their quality of life impacted (or not).  We have the SPARTAN statistics on that, but we really don’t know until more men from our Malecare community report back to us regarding their Erleada experience.  So we have some questions.  Do men live longer while taking Erleada and, if so, will their increased lifespan be worth enduring whatev